DalsnaFinance

BofA raises Merck stock price target to $141 on cancer drug potential

Stocks Investing.com By Investing.com 30 Jun 2026 10:17 1 min read
BofA raises Merck stock price target to $141 on cancer drug potential

BofA raises Merck stock price target to $141 on cancer drug potential  Investing.com

BofA raises Merck stock price target to $141 on cancer drug potential Investing.com

Read the full story on Investing.com → Opens the original article on news.google.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.